Cotinine (Nicotine)

Cotinine (Nicotine Metabolite) Test Device

Nicotine is the number 1 abused drug and avoidable cause of death in the United States. Not to mention, routine exposure to second hand smoke is considered to be a dangerous health risk. So for these reasons alone, health and insurance companies test routinely for tobacco usage.

The Cotinine Test Device is a rapid screening test designed to detect Cotinine, the major metabolite of Nicotine, in human urine at a level of 200 ng/mL. This test utilizes a monoclonal antibody to selectively detect elevated levels of Cotinine in urine. The window of detection for Cotinine in urine at a cutoff level of 200 ng/mL is ~ 2 hours-10 days after smoking. The window of detection depends on duration, amount, frequency of tobacco use, as well as other factors. The accuracy rate of this test is 99%.

The Cotinine Test Device provides only a qualitative, preliminary analytical result so it is recommended that a secondary analytical method (i.e. GC/MS) be used to obtain a confirmed result. This test is NOT available for sale in Europe.

Cotinine Levels And What They Mean:

• <10 ng/mL – Non-active smoker.
• 10 ng/mL to 100 ng/mL – Light smoker or moderate passive exposure.
• >300 ng/mL – Considered to be heavy smokers (20+ cigarettes/day). 

Available in the following formats:

• Cassettes with pipettes (packaged 40 per canister)

Please visit our Sales Brochure Page to view our Product List for information on available configurations.

For Package Inserts (Instructions for Use) or Brochures, please visit the “RESOURCES” section of our web site. To request a login contact us at info@alfascientific.com